Unity Biotechnology
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-0.08-0.152.930.29
Price/Sales ratio
4.060.390.180.11
Earnings per Share (EPS)
$-1.99$-1.11$0.06$0.6

Historical Multiples (2016 – 2023)

2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-1.88-1.28-6.01-4.20-2.90-1.35-0.45-0.71-0.54-4.20
Price/Sales ratio
N/A41.41N/AN/AN/A17.03110.23N/A74.42N/A
Price/Book Value ratio
-1.370.632.862.603.211.360.381.000.263.21
Price/Cash Flow ratio
-3.49-1.49-8.11-4.34-3.40-1.80-0.50-0.76-0.58-4.34
Price/Free Cash Flow ratio
-3.07-1.42-7.94-4.25-3.37-1.80-0.50-0.76-0.58-4.25
Price/Earnings Growth ratio
N/A-0.020.070.11-0.550.030.010.01-0.00-0.55
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/A-2604.26%N/AN/AN/A39.79%-823.72%N/A100%N/A
Operating Profit Margin
N/A-3300.14%N/AN/AN/A-1184.46%-24394.91%N/A-12958.71%N/A
Pretax Profit Margin
N/A-3231.25%N/AN/AN/A-1269.33%-25392.79%N/A-13606.74%N/A
Net Profit Margin
N/A-3231.25%N/AN/AN/A-1254.99%-24469.06%N/A-13606.74%N/A
Effective Tax Rate
-38.02%2.36%-4.01%8.88%2.10%1.12%3.63%N/AN/A2.10%
Return on Assets
-31.45%-43.77%-42.12%-49.51%-58.77%-48.14%-46.43%-60.67%-25.82%-49.51%
Return On Equity
73.19%-49.15%-47.54%-62.02%-110.84%-100.78%-86.38%-140.36%-54.41%-62.02%
Return on Capital Employed
-20.27%-48.45%-48.22%-66.90%-66.21%-52.42%-54.97%-77.21%-29.20%-66.90%
Liquidity Ratios
Current Ratio
N/AN/A10.437.526.97N/AN/AN/A4.926.97
Quick Ratio
25.3011.2510.437.526.975.444.935.944.836.97
Cash ratio
24.190.920.922.171.231.980.642.520.641.23
Days of Sales Outstanding
N/A365N/AN/AN/AN/A363.45N/AN/AN/A
Days of Inventory outstanding
N/A0.00N/AN/AN/AN/A-39.34N/AN/AN/A
Operating Cycle
N/A365.00N/AN/AN/AN/A324.10N/AN/AN/A
Days of Payables Outstanding
2.29K23.22811.53710.67270.70251.57299.7025.56N/A270.70
Cash Conversion Cycle
N/A341.77N/AN/AN/A-251.5724.40N/AN/AN/A
Debt Ratios
Debt Ratio
N/AN/AN/AN/A0.150.170.16N/A0.460.46
Debt Equity Ratio
N/AN/AN/AN/A0.290.360.30N/A0.860.86
Long-term Debt to Capitalization
N/AN/AN/AN/A0.220.230.14N/A0.360.36
Total Debt to Capitalization
N/AN/AN/AN/A0.220.260.23N/A0.410.41
Interest Coverage Ratio
N/AN/AN/AN/A-72.70N/AN/AN/A-17.93-72.70
Cash Flow to Debt Ratio
N/AN/AN/AN/A-3.19-2.09-2.50N/A-0.63-0.63
Company Equity Multiplier
-2.321.121.121.251.882.091.862.311.861.25
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/A-27.75N/AN/AN/A-9.41-216.22N/A-126.51N/A
Free Cash Flow / Operating Cash Flow Ratio
1.131.041.021.021.001.001.001.001.001.00
Cash Flow Coverage Ratio
N/AN/AN/AN/A-3.19-2.09-2.50N/A-0.63-0.63
Short Term Coverage Ratio
N/AN/AN/AN/AN/A-14.74-5.38N/A-3.15N/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A